Intraductal administration of an nk1 receptor antagonist attenuates the inflammatory response to retrograde infusion of radiological contrast in rats: Implications for the pathogenesis and prevention of ercp-induced pancreatitis

Nursing

Volumn 27, Issue 1, 1997, Pages

  He, Zhi Jun ^a   Winston, John H ^a   Yusuf, Tony E ^a   Micci, Maria Adelaide ^a   Elfert, Asem ^a   Xiao, Shu Yuan ^b   Pasricha, Pankaj J ^a  

^a Enteric Neuromuscular Disorders and Visceral Pain Center   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acute pancreatitis; ERCP; Neurogenic inflammation; NK 1 receptor; Substance P

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; AMYLASE; BIPHENYL DERIVATIVE; CONTRAST MEDIUM; NEUROKININ 1 RECEPTOR; PEROXIDASE;

ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; EDEMA; ENDOCYTOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYMOLOGY; INFLAMMATION; MALE; METABOLISM; PANCREAS; PANCREATITIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

AMYLASES; ANIMALS; BIPHENYL COMPOUNDS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONTRAST MEDIA; EDEMA; ENDOCYTOSIS; INFLAMMATION; MALE; PANCREAS; PANCREATITIS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1;

EID: 0842337816     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas. 1991; 6:350-367.
2. Sherman S, Hawes RH, Rathgaber SW, et al. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc. 1994; 40:422-427.
3. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion. 1993; 54:105-111.
4. Odes HS, Novis BN, Barbezat GO, et al. Effect of calcitonin on the serum amylase level after endoscopic retrograde cholangiopancreatography. Digestion. 1977; 16:180-184.
5. Arcidiacono R, Gambitta P, Rossi A, et al. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy. 1994; 26:715-718.
6. Sternleib JM, Aronchick CA, Retig JN, et al. A multicenter, randomized controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol. 1992; 87:1561-1566.
7. De Palma JD, Catazano C. Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol. 1999; 94:982-985.
8. Dumot J, Conwell D, O’Connor B, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol. 1998; 93:61-65.
9. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial. Gastrointest Endosc. 2002; 55:470-475.
10. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med. 1996; 335:919-923.
11. Pasricha P. Prevention of ERCP-induced pancreatitis: success at last. Gastroenterology. 1997; 112:1415-1417.
12. Devière J, Le Moine O, Van Laethem J, et al. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology. 2001; 120:498-505.
13. Rabenstein T. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc. 2002; 55:476-483.
14. Andriulli A. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc. 2000; 51:1-7.
15. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A. 1998; 95:4760-4765.
16. Grady EF, Yoshimi SK, Maa J, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol. 2000; 130:505-512.
17. Maa J, Grady EF, Yoshimi SK, et al. Substance P is a determinant of lethality in diet-induced hemorrhagic pancreatitis in mice. Surgery. 2000; 128:232-239.
18. Lowe 3rd, JA Drozda SE, Snider RM, et al. Discovery of CP-96, 345 and its characterization in disease models involving substance P. Regulatory Peptides 1993; 46:20-23.
19. Kivisaari L. Contrast absorption and pancreatic inflammation following experimental ERCP. Investigative Radiol. 1979; 14:493-497.
20. Tito JM, Rudnicki M, Jones DH, et al. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat. Am J Surg. 1993; 165:690-696.
21. Vigna SR, Bowden JJ, McDonald DM, et al. Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells. J Neurosci. 1994; 14:834-845.
22. Akashi R, Kiyozumi T, Tanaka T, et al. Mechanism of pancreatitis caused by ERCP. Gastrointest Endosc 2002; 55:50-54.
23. Bub H, Burner W, Riemann JF, et al. Morphology of the pancreatic ductal epithelium after traumatization of the papilla of Vater or endoscopic retrograde pancreatography with various contrast agents. Scand J Gastroenterol. 1983; 18:581-592.
24. Marks JM, Dunkin BJ, Shillingstad BL, et al. Pretreatment with allopurinol diminishes pancreatography-induced pancreatitis in a canine model. Gastrointest Endosc. 1998; 48:180-183.
25. Ohlsson K, Olsson R, Bjork P, et al. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs. Scand J Gastroenterol. 1989; 24:693-704.
26. Wakayama T, Itoh T, Shibayama K, et al. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs. Am J Gastroenterol. 1989; 84:272-278.
27. Nathan JD, Patel AA, McVey DC, et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2001; 281:G1322-G1328.
28. Waldron RL, Luse SA, Wollowick HE, et al. Demonstration of a retrograde pancreatic pathway: correlation of roentgenographic and electron microscopic studies. Am J Roentgenol. 1971; 111:695-699.